Search results
Seagen's (SGEN) Breast Cancer Study on Tuksya Combo Meets Goal
Zacks via Yahoo Finance· 9 months agoSeagen Inc. SGEN announced positive top-line results from its late-stage HER2CLIMB-02 study,...
New data sets stage for broader use of AstraZeneca breast cancer drug
Reuters via Yahoo News· 2 years agoAstraZeneca and Daiichi Sankyo's Enhertu extended survival by more than six months in patients with...
Roche sceptical about investing more in 'guided-missile' ADC cancer drugs
Reuters via Yahoo News· 2 years agoMANNHEIM (Reuters) -Roche remains sceptical about investing more in antibody-drug conjugates (ADCs),...
AbbVie joins ADC dealmaking with $10B ImmunoGen buyout
BioPharma Dive via Yahoo Finance· 5 months agoAbbVie is expanding its investment in targeted cancer medicines, announcing Thursday a $10.1 billion...
Seagen's breast cancer therapy succeeds in late-stage study
Reuters via Yahoo News· 9 months agoPfizer in March agreed to acquire Seagen and its targeted therapies in a $43 billion deal to help...
Why Shares of Ambrx Biopharma Fell Tuesday
Motley Fool· 1 year agoWhat happened Shares of Ambrx BioPharma (NYSE: AMAM) fell 28.1% for the day as of late Tuesday afternoon. The clinical-stage biotech announced Monday...
AstraZeneca (AZN) Drugs Get CHMP Recommendation for Breast Cancer
Zacks via Yahoo Finance· 2 years agoThe EMA's Committee for Medicinal Products for Human Use recommends granting marketing approval to...
Seagen Inc. (SGEN) Q3 2022 Earnings Call Transcript
Motley Fool· 2 years agoSpeakers on today's call will be Roger Dansey, interim chief executive officer and chief medical officer; Todd Simpson, chief financial officer; and Chip...
Merck cancer drug deal caps pharma investment influx into ‘ADC’ field
BioPharma Dive via Yahoo Finance· 7 months agoWith the alliance, Merck joins Pfizer, AstraZeneca and Gilead in staking major bets on the potential...
'I'm a people lover': Cancer patient volunteers for clinical trials to help others
Savannah Morning News via Yahoo News· 6 months agoCancer care is constantly improving at Lewis Cancer Research Pavilion and clinical trial...